Mosunetuzumab Plus Polatuzumab Vedotin Demonstrates a Favorable Safety Profile and Efficacy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma ( LBCL): Primary Analysis of a Phase Ib/II Study

被引：7

作者：

Budde, L. Elizabeth ^{[1
]}

Olszewski, Adam J. ^{[2
]}

Assouline, Sarit ^{[3
]}

Lossos, Izidore S. ^{[4
]}

Diefenbach, Catherine ^{[5
]}

Kamdar, Manali ^{[6
]}

Ghosh, Nilanjan ^{[7
]}

Modi, Dipenkumar ^{[8
]}

Sabry, Waleed ^{[9
]}

Naik, Seema ^{[10
]}

Mehta, Amitkumar ^{[11
]}

Nakhoda, Shazia K. ^{[12
]}

Smith, Stephen D. ^{[13
]}

Dorritie, Kathleen ^{[14
]}

Jia, Ting ^{[15
]}

Pham, Song ^{[16
]}

Huw, Ling-Yuh ^{[17
]}

Wu, Hao ^{[17
]}

To, Iris ^{[17
]}

Wei, Michael C. ^{[17
]}

Chavez, Julio C. ^{[18
]}

机构：

[1] City Hope Natl Med Ctr, Duarte, CA USA

[2] Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USA

[3] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada

[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA

[5] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA

[6] Univ Colorado, Aurora, CO USA

[7] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[8] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA

[9] Univ Saskatchewan, Saskatoon Canc Ctr, Coll Med, Saskatoon, SK, Canada

[10] Penn State Canc Inst, Hershey, PA USA

[11] Univ Alabama Birmingham, Birmingham, AL USA

[12] Fox Chase Canc Ctr, Philadelphia, PA USA

[13] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA

[14] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[15] Roche China Holding Ltd, Shanghai, Peoples R China

[16] F Hoffmann Roche Ltd, Basel, Switzerland

[17] Genentech Inc, San Francisco, CA USA

[18] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174209

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[31] Safety and efficacy of polatuzumab vedotin plus obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study
Phillips, Tycel
Brunvand, Mark
Chen, Andy I.
Essell, James
Chiappella, Annalisa
Diefenbach, Catherine
Cheng, Ji
Ramies, David
Hirata, Jamie
Morschhauser, Franck
Flinn, Ian W.
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (01) : E24 - E27
[32] Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients
Song, Yuqin
Zhang, Qingyuan
Cai, Qingqing
Song, Yongping
Zhang, Liling
He, Pengcheng
Wang, Li
Hirata, Jamie
Musick, Lisa
Deng, Rong
Liu, Wenxin
Wang, Xin
Zhu, Jun
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (07)
[33] Mosunetuzumab and Polatuzumab Vedotin Demonstrates Preliminary Efficacy in Elderly Unfit/Frail Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Olszewski, Adam J.
Eradat, Herbert
Avigdor, Abraham
Horowitz, Netanel A.
Babu, Sunil
Levi, Itai
McKinney, Matthew
Lee, Seung Tae
Bergua Burgues, Juan Miguel
Rodriguez Izquierdo, Antonia
Bastos-Oreiro, Mariana
Ganzel, Chezi
Kim, Tae Min
Jeon, Youngwoo
Taszner, Michal
Narkhede, Mayur
Kim, Won Seog
Shin, Ho-Jin
Lavie, David
Woszczyk, Dariusz
Dunshee, Diana
Kapp, Amy V.
Zhou, Mingzhu
Batlevi, Connie Lee
Ead, Wahib
Sellam, Gila
Jurczak, Wojciech
BLOOD, 2023, 142
[34] Efficacy and safety of polatuzumab-vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma: A systematic review and meta-analysis☆
Farooqi, Hanzala Ahmed
Ullah, Muhammad Saffi
Raza, Ahmed
Sadiq, Zain
Shaikh, Wardah Ali
Muhammad, Rahmah
Hussain, Muhammad Shoaib
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 207
[35] Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world
Vodicka, Prokop
Benesova, Katerina
Janikova, Andrea
Prochazka, Vit
Belada, David
Mocikova, Heidi
Steinerova, Katerina
Duras, Juraj
Karban, Josef
Hanackova, Veronika
Sykorova, Alice
Obr, Ales
Trneny, Marek
EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (02) : 162 - 165
[36] Polatuzumab vedotin plus obinutuzumab plus venetoclax in patients with relapsed/refractory (R/R) follicular lymphoma (FL): Primary analysis of a phase 1b/2 trial.
Bannerji, Rajat
Yuen, Sam
Phillips, Tycel Jovelle
Arthur, Christopher
Isufi, Iris
Marlton, Paula
Seymour, John Francis
Corradini, Paolo
Molinari, Annalia
Gritti, Giuseppe
Emmons, Robert
Hirata, Jamie
Musick, Lisa
Saha, Sourish
Croft, Brandon
Flowers, Christopher
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[37] Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma
Lu, Tong
Gibiansky, Leonid
Li, Xiaobin
Li, Chunze
Shi, Rong
Agarwal, Priya
Hirata, Jamie
Miles, Dale
Chanu, Pascal
Girish, Sandhya
Jin, Jin Yan
Lu, Dan
LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2905 - 2914
[38] Glofitamab monotherapy in pts with relapsed/refractory (R/R) large B-cell lymphoma (LBCL): Extended follow-up and landmark analyses from a pivotal phase II study
Falchi, Lorenzo
Carlo-Stella, Carmelo
Morschhauser, Franck
Hutchings, Martin
Bachy, Emmanuel
Cartron, Guillaume
Khan, Cyrus
Tani, Monica
Martinez-Lopez, Joaquin
Bartlett, Nancy L.
Salar, Antonio
Brody, Joshua
Leppa, Sirpa
Mulvihill, Estafania
Lundberg, Linda
Relf, James
Xie, Yuying
Bottos, Alessia
Humphrey, Kathryn
Dickinson, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[39] A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Kambhampati, Swetha
Kallam, Avyakta
Borogovac, Azra
Chen, Lu
Puverel, Sandrine
Johnson, Jennifer
Melgar, Ivana
Baird, John H.
Danilov, Alexey
Godfrey, James
Khan, Niloufer
Mei, Matthew
Phillips, Tycel J. J.
Siddiqi, Tanya
Shouse, Geoffrey
Zain, Jasmine
Kwak, Larry W.
Rosen, Steven T.
Forman, Stephen J.
Song, Joo Y.
Herrera, Alex F.
Budde, Elizabeth
BLOOD, 2024, 144 : 17421 - 17422
[40] Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab
Amaya, M. L.
Jimeno, A.
Kamdar, M.
DRUGS OF TODAY, 2020, 56 (04) : 287 - 294

← 1 2 3 4 5 →